Resolvin E1 derived from eicosapentaenoic acid prevents hyperinsulinemia and hyperglycemia in a host genetic manner
A. Pal, A. E. Al-Shaer, W. Guesdon, M. J. Torres, M. Armstrong, K. Quinn, T. Davis, N. Reisdorph, P. D. Neufer, E. E. Spangenburg, I. Carroll, R. P. Bazinet, G. V. Halade, J. Claria, S. R. Shaikh
This study shows EPA prevents hyperinsulinemia and hyperglycemia via RvE1, which acts through ERV1/ChemR23, and highlights host genetic variation in metabolic responses.
bioRxiv · Mar 31, 2020Biochemistry